TNON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Tenon Medical Inc (TNON) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown significant revenue growth and received FDA clearance for a new product, the stock's technical indicators are neutral, and there are no strong proprietary trading signals or significant trading trends to suggest immediate upside potential. The financial performance, while improving, still reflects losses, and the pre-market price is slightly declining.
The MACD is positive and expanding, suggesting slight bullish momentum. RSI is neutral at 57.193, and moving averages are converging, indicating no clear trend. Key support is at 0.753, and resistance is at 0.902. Pre-market price is slightly down by -0.78%, reflecting weak sentiment.
Full-year revenue increased by 20% in 2025, with Q4 revenue showing 92% growth.
FDA 510(k) clearance for the SImmetry+ SI-Joint Fusion System.
$7.15 million financing completed for expansion and product launches.
Pre-market price is down by -0.78%.
The stock has an 80% chance to decline by -1.12% in the next day.
EPS remains negative at -$0.29, reflecting ongoing losses.
In Q4 2025, revenue grew 92% YoY to $1.5 million, and full-year revenue rose 20% to $3.9 million. However, the company remains unprofitable, with a Q4 GAAP EPS of -$0.29. Gross margin improved to 65.9%, indicating better cost efficiency.
No analyst rating or price target changes available for TNON.
